These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9149703)

  • 1. Bone-marrow transplantation in aspartylglucosaminuria.
    Autti T; Santavuori P; Raininko R; Renlund M; Rapola J; Saarinen-Pihkala U
    Lancet; 1997 May; 349(9062):1366-7. PubMed ID: 9149703
    [No Abstract]   [Full Text] [Related]  

  • 2. Two novel mutations in a Canadian family with aspartylglucosaminuria and early outcome post bone marrow transplantation.
    Laitinen A; Hietala M; Haworth JC; Schroeder ML; Seargeant LE; Greenberg CR; Aula P
    Clin Genet; 1997 Mar; 51(3):174-8. PubMed ID: 9137882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correction of peripheral lysosomal accumulation in mice with aspartylglucosaminuria by bone marrow transplantation.
    Laine M; Richter J; Fahlman C; Rapola J; Renlund M; Peltonen L; Karlsson S; Jalanko A
    Exp Hematol; 1999 Sep; 27(9):1467-74. PubMed ID: 10480438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Molecular genetics of aspartylglucosaminuria].
    Palotie L; Ikonen E; Syvänen AC; Halila R; Enomaa N; Heiskanen T; Grön K; Aula P
    Duodecim; 1991; 107(23-24):1916-25. PubMed ID: 1366100
    [No Abstract]   [Full Text] [Related]  

  • 5. [A family with two children diagnosed with aspartylglucosaminuria-case report and literature review].
    Liu Y; Zou L; Meng Y; Zhang Y; Shi X; Ju J; Yang G; Hu L; Chen X
    Zhonghua Er Ke Za Zhi; 2014 Jun; 52(6):455-9. PubMed ID: 25190167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Aspartylglucosaminuria].
    Yamaguchi S
    Ryoikibetsu Shokogun Shirizu; 1998; (19 Pt 2):466-8. PubMed ID: 9645112
    [No Abstract]   [Full Text] [Related]  

  • 7. Reduction in head size in patients with aspartylglucosaminuria.
    Arvio M; Arvio P; Hurmerinta K; Pirinen S; Sillanpää M
    Acta Neurol Scand; 2005 Nov; 112(5):335-7. PubMed ID: 16218917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenovirus-mediated gene transfer results in decreased lysosomal storage in brain and total correction in liver of aspartylglucosaminuria (AGU) mouse.
    Peltola M; Kyttälä A; Heinonen O; Rapola J; Paunio T; Revah F; Peltonen L; Jalanko A
    Gene Ther; 1998 Oct; 5(10):1314-21. PubMed ID: 9930336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations causing aspartylglucosaminuria (AGU): a lysosomal accumulation disease.
    Ikonen E; Peltonen L
    Hum Mutat; 1992; 1(5):361-5. PubMed ID: 1301945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone marrow transplantation in aspartylglucosaminuria--histopathological and MRI study.
    Autti T; Rapola J; Santavuori P; Raininko R; Renlund M; Liukkonen E; Lauronen L; Wirtavuori K; Hietala M; Saarinen-Pihkala U
    Neuropediatrics; 1999 Dec; 30(6):283-8. PubMed ID: 10706021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysosomal storage disorders: the need for better pediatric recognition and comprehensive care.
    Wilcox WR
    J Pediatr; 2004 May; 144(5 Suppl):S3-14. PubMed ID: 15126978
    [No Abstract]   [Full Text] [Related]  

  • 12. Applications of PCR in the diseases of genetic isolates.
    Peltonen L; Ikonen E; Paunio T
    Ann Med; 1992 Jun; 24(3):191-4. PubMed ID: 1627315
    [No Abstract]   [Full Text] [Related]  

  • 13. Correction of deficient enzyme activity in a lysosomal storage disease, aspartylglucosaminuria, by enzyme replacement and retroviral gene transfer.
    Enomaa N; Danos O; Peltonen L; Jalanko A
    Hum Gene Ther; 1995 Jun; 6(6):723-31. PubMed ID: 7548272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissection of the molecular pathology of aspartylglucosaminuria provides the basis for DNA diagnostics and future therapeutic interventions.
    Ikonen E; Syvänen AC; Peltonen L
    Scand J Clin Lab Invest Suppl; 1993; 213():19-27. PubMed ID: 8322015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone marrow transplantation in young aspartylglucosaminuria mice: improved clearance of lysosomal storage in brain by using wild type as compared to heterozygote donors.
    Laine M; Ahtiainen L; Rapola J; Richter J; Jalanko A
    Bone Marrow Transplant; 2004 Dec; 34(11):1001-3. PubMed ID: 15489878
    [No Abstract]   [Full Text] [Related]  

  • 16. Mice with an aspartylglucosaminuria mutation similar to humans replicate the pathophysiology in patients.
    Jalanko A; Tenhunen K; McKinney CE; LaMarca ME; Rapola J; Autti T; Joensuu R; Manninen T; Sipilä I; Ikonen S; Riekkinen P; Ginns EI; Peltonen L
    Hum Mol Genet; 1998 Feb; 7(2):265-72. PubMed ID: 9425233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Allogeneic bone marrow transplantation in the treatment of (lysosomal) storage diseases].
    Maaswinkel-Mooij PD; Poorthuis BJ; Hoogerbrugge PM; Brouwer OF; Vossen JM
    Ned Tijdschr Geneeskd; 1998 Jan; 142(4):169-74. PubMed ID: 9557021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone marrow transplantation and gene therapy for lysosomal storage diseases.
    Hoogerbrugge PM; Valerio D
    Bone Marrow Transplant; 1998 Apr; 21 Suppl 2():S34-6. PubMed ID: 9630322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New concepts in the diagnosis and treatment of lysosomal and peroxisomal disorders.
    Moser HW
    Curr Opin Neurol Neurosurg; 1992 Jun; 5(3):355-8. PubMed ID: 1623264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of nonviral promoters in adenovirus-mediated gene therapy: reduction of lysosomal storage in the aspartylglucosaminuria mouse.
    Virta S; Rapola J; Jalanko A; Laine M
    J Gene Med; 2006 Jun; 8(6):699-706. PubMed ID: 16518877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.